FDA Pushes Tougher Controls On Hydrocodone Painkillers
Law360, New York (October 24, 2013, 8:37 PM EDT) -- In a long-awaited move, the U.S. Food and Drug Administration is recommending putting more restrictions on Vicodin and other hydrocodone combination painkillers, some of the most prescribed and abused drugs in the country, the agency announced Thursday.
The FDA intends to advise the U.S. Department of Health and Human Services to reclassify the drugs from Schedule III of the Controlled Substances Act to Schedule II. Drugs in that class require a written prescription, cannot be refilled without subsequent prescriptions, and must be kept locked and closely inventoried by pharmacies.
"This determination comes after a thorough and careful analysis of extensive scientific...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!